IL304824A - Fospropofol methods and compositions - Google Patents

Fospropofol methods and compositions

Info

Publication number
IL304824A
IL304824A IL304824A IL30482423A IL304824A IL 304824 A IL304824 A IL 304824A IL 304824 A IL304824 A IL 304824A IL 30482423 A IL30482423 A IL 30482423A IL 304824 A IL304824 A IL 304824A
Authority
IL
Israel
Prior art keywords
fospropofol
compositions
methods
fospropofol methods
Prior art date
Application number
IL304824A
Other languages
Hebrew (he)
Original Assignee
Epalex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/168,365 external-priority patent/US11547714B2/en
Priority claimed from US17/217,656 external-priority patent/US11207334B1/en
Priority claimed from US17/387,059 external-priority patent/US11478490B1/en
Priority claimed from US17/465,966 external-priority patent/US20220313711A1/en
Priority claimed from US17/466,016 external-priority patent/US11439653B1/en
Application filed by Epalex Corp filed Critical Epalex Corp
Publication of IL304824A publication Critical patent/IL304824A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL304824A 2021-02-05 2023-07-30 Fospropofol methods and compositions IL304824A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US17/168,365 US11547714B2 (en) 2020-02-05 2021-02-05 Fospropofol salts, methods and compositions
US17/217,656 US11207334B1 (en) 2021-03-30 2021-03-30 Fospropofol formulations
US17/387,059 US11478490B1 (en) 2021-03-30 2021-07-28 Fospropofol formulations
US17/465,966 US20220313711A1 (en) 2021-03-30 2021-09-03 Fospropofol formulations
US17/466,016 US11439653B1 (en) 2021-03-30 2021-09-03 Fospropofol formulations
PCT/US2021/065225 WO2022169520A1 (en) 2021-02-05 2021-12-27 Fospropofol methods and compositions

Publications (1)

Publication Number Publication Date
IL304824A true IL304824A (en) 2023-09-01

Family

ID=82741701

Family Applications (1)

Application Number Title Priority Date Filing Date
IL304824A IL304824A (en) 2021-02-05 2023-07-30 Fospropofol methods and compositions

Country Status (6)

Country Link
EP (1) EP4288062A1 (en)
JP (1) JP2024508686A (en)
AU (1) AU2021426502A1 (en)
CA (1) CA3207194A1 (en)
IL (1) IL304824A (en)
WO (1) WO2022169520A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5577021B2 (en) * 2005-02-17 2014-08-20 アボット・ラボラトリーズ Transmucosal administration of pharmaceutical compositions for treating and preventing disorders in animals
AU2006315610A1 (en) * 2005-11-14 2007-05-24 Peter D. Winch Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts
DK2661280T3 (en) * 2011-01-04 2019-03-04 Novaliq Gmbh O / V EMULSIONS INCLUDING SEMIFLUORINATED ALKANES
US11331271B2 (en) * 2016-05-27 2022-05-17 The Johns Hopkins University Buccal, sublingual and intranasal delivery of fospropofol

Also Published As

Publication number Publication date
WO2022169520A1 (en) 2022-08-11
AU2021426502A1 (en) 2023-08-17
CA3207194A1 (en) 2022-08-11
JP2024508686A (en) 2024-02-28
EP4288062A1 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
IL290325A (en) Biopharmacuetical compositions and related methods
GB202111040D0 (en) Compositions and methods
GB202004677D0 (en) Methods and compositions
GB202110091D0 (en) Methods and compositions
SG11202108262VA (en) Bacterialcidal methods and compositions
GB202002926D0 (en) Compositions and uses thereof
IL304824A (en) Fospropofol methods and compositions
GB202408093D0 (en) Compositions and methods
GB202214719D0 (en) Compositions and methods
IL310092A (en) Compositions and methods
IL309079A (en) Methods and compositions
GB202116554D0 (en) Methods and compositions
GB202113904D0 (en) Methods and compositions
GB202110572D0 (en) Compositions and methods
GB202105367D0 (en) Methods and compositions
GB202101962D0 (en) Methods and compositions
GB202020623D0 (en) Methods and compositions
GB202013858D0 (en) Compositions and methods
GB202009256D0 (en) Compositions and methods
GB202002707D0 (en) Compositions and methods
GB202001526D0 (en) Methods and compositions
GB202000840D0 (en) Compositions and methods
GB202000351D0 (en) Methods and compositions
GB202316109D0 (en) Methods and compositions
GB202316106D0 (en) Methods and compositions